The Scottish Metabolomics Facility ScotMet is to gain four Thermo Fisher Scientific mass spectrometers...
The Scottish Metabolomics Facility ScotMet is to gain four Thermo Fisher Scientific mass spectrometers. ScotMet is funded by the Scottish Universities Life Science Alliance (SULSA) and is run jointly by the Universities of Glasgow and Strathclyde. The facility combines mass spectrometry, separations technology and bioinformatics. According to Thermo Fisher, the facility will install four instruments, including an LTQ Orbitrap Velos with ETD and FAIMS source, a DSQ-II GC–MS and two Exactive LC–MS benchtop instruments.
In a statement from the company, Dr Dave Watson at the University of Strathclyde said, "We've had excellent results over the past three years of undertaking metabolomics experiments with the LTQ Orbitrap, and the addition of the LTQ OT Velos, Exactives and GC–MS capability will expedite existing projects and extend the range of important biological and medical problems with which we can work."
For more information about these mass spectrometers visit www.thermo.com/metabolomics
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.